Stockreport

J&J MET antibody nabs accelerated review status for certain lung cancer patients [Seeking Alpha]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF Healthcare J&J MET antibody nabs accelerated review status for certain lung cancer patients Mar. 10, 2020 4:14 PM ET | Johnson & Johnson (JNJ) Douglas W. House The FDA [Read more]